PDA

View Full Version : Johnson & Johnson to Settle Risperdal Improper Marketing Case


news
11-04-2013, 05:59 PM
Federal officials said the drug giant promoted the antipsychotic drug as a way to treat dementia patients for many ailments, when it was only approved for schizophrenia.http://rss.nytimes.com/c/34625/f/642562/s/334aebf6/sc/30/mf.gif
http://res3.feedsportal.com/social/twitter.png (http://share.feedsportal.com/share/twitter/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F05%2 Fbusiness%2Fjohnson-johnson-to-settle-risperdal-improper-marketing-case.html%3Fpartner%3Drss%26emc%3Drss&t=Johnson+%26+Johnson+to+Settle+Risperdal+Improper +Marketing+Case) http://res3.feedsportal.com/social/facebook.png (http://share.feedsportal.com/share/facebook/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F05%2 Fbusiness%2Fjohnson-johnson-to-settle-risperdal-improper-marketing-case.html%3Fpartner%3Drss%26emc%3Drss&t=Johnson+%26+Johnson+to+Settle+Risperdal+Improper +Marketing+Case) http://res3.feedsportal.com/social/linkedin.png (http://share.feedsportal.com/share/linkedin/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F05%2 Fbusiness%2Fjohnson-johnson-to-settle-risperdal-improper-marketing-case.html%3Fpartner%3Drss%26emc%3Drss&t=Johnson+%26+Johnson+to+Settle+Risperdal+Improper +Marketing+Case) http://res3.feedsportal.com/social/googleplus.png (http://share.feedsportal.com/share/gplus/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F05%2 Fbusiness%2Fjohnson-johnson-to-settle-risperdal-improper-marketing-case.html%3Fpartner%3Drss%26emc%3Drss&t=Johnson+%26+Johnson+to+Settle+Risperdal+Improper +Marketing+Case) http://res3.feedsportal.com/social/email.png (http://share.feedsportal.com/share/email/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F05%2 Fbusiness%2Fjohnson-johnson-to-settle-risperdal-improper-marketing-case.html%3Fpartner%3Drss%26emc%3Drss&t=Johnson+%26+Johnson+to+Settle+Risperdal+Improper +Marketing+Case)


http://da.feedsportal.com/r/180263529180/u/79/f/642562/c/34625/s/334aebf6/sc/30/rc/1/rc.img (http://da.feedsportal.com/r/180263529180/u/79/f/642562/c/34625/s/334aebf6/sc/30/rc/1/rc.htm)
http://da.feedsportal.com/r/180263529180/u/79/f/642562/c/34625/s/334aebf6/sc/30/rc/2/rc.img (http://da.feedsportal.com/r/180263529180/u/79/f/642562/c/34625/s/334aebf6/sc/30/rc/2/rc.htm)
http://da.feedsportal.com/r/180263529180/u/79/f/642562/c/34625/s/334aebf6/sc/30/rc/3/rc.img (http://da.feedsportal.com/r/180263529180/u/79/f/642562/c/34625/s/334aebf6/sc/30/rc/3/rc.htm)

http://da.feedsportal.com/r/180263529180/u/79/f/642562/c/34625/s/334aebf6/a2.img (http://da.feedsportal.com/r/180263529180/u/79/f/642562/c/34625/s/334aebf6/a2.htm)http://pi.feedsportal.com/r/180263529180/u/79/f/642562/c/34625/s/334aebf6/a2t.img

More... (http://www.nytimes.com/2013/11/05/business/johnson-johnson-to-settle-risperdal-improper-marketing-case.html?partner=rss&emc=rss)